Achillion Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ACHN and buy or sell other stocks, ETFs, and their options commission-free!

About ACHN

Antiaging Quantum Living, Inc. engages in the provision of online advertising services. The firm offers services with a focus on website development, maintenance, and promotion. 

CEO
Barry Wan
CEOBarry Wan
Employees
Employees
Headquarters
Flushing, New York
HeadquartersFlushing, New York
Founded
2014
Founded2014
Employees
Employees

ACHN Key Statistics

Market cap
231.70M
Market cap231.70M
Price-Earnings ratio
-29.38
Price-Earnings ratio-29.38
Dividend yield
Dividend yield
Average volume
5.56
Average volume5.56
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.56
52 Week high$2.56
52 Week low
$0.303
52 Week low$0.303

Stock Snapshot

Achillion Pharmaceuticals(ACHN) stock is priced at $6.76, giving the company a market capitalization of 231.7M. It carries a P/E multiple of -29.38.

On 2026-04-14, Achillion Pharmaceuticals(ACHN) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 5.56.

Over the past 52 weeks, Achillion Pharmaceuticals(ACHN) stock has traded between a high of $2.56 and a low of $0.30.

Over the past 52 weeks, Achillion Pharmaceuticals(ACHN) stock has traded between a high of $2.56 and a low of $0.30.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.